See Stories from Region:
Filter by Date:
 
  • close  
  • close  
RSS – Health 
News > Health

Featured

November 3, 2016 - 06:08 AM

Advancements in ArQule’s Proprietary Pipeline to be Highlighted at the 2016 American Society of Hematology Annual Meeting

BTK inhibitor, ARQ 531, potently inhibits wild type and C481S mutant BTK and is superior…

Read More
November 3, 2016 - 05:01 AM

Revance Announces Initiation of Phase 2 Trial of RT002 Injectable to Treat Plantar Fasciitis

- Topline Results Expected in 2017 -

Read More
November 3, 2016 - 04:02 AM

Omeros Files Orphan Drug Application for OMS721 in Immunoglobulin A Nephropathy

-- Omeros Continues to Expand Orphan Indications for OMS721 --

Read More

Latest

November 3, 2016 - 06:08 AM

Advancements in ArQule’s Proprietary Pipeline to be Highlighted at the 2016 American Society of Hematology Annual Meeting

BTK inhibitor, ARQ 531, potently inhibits wild type and C481S mutant BTK and is superior to ibrutinib in TCL1 mouse model for CLLAKT…

Read More
November 3, 2016 - 05:01 AM

Revance Announces Initiation of Phase 2 Trial of RT002 Injectable to Treat Plantar Fasciitis

- Topline Results Expected in 2017 -

Read More
November 3, 2016 - 04:02 AM

Omeros Files Orphan Drug Application for OMS721 in Immunoglobulin A Nephropathy

-- Omeros Continues to Expand Orphan Indications for OMS721 --

Read More
November 3, 2016 - 04:02 AM

Ignyta Announces Presentation at the CTOS 21st Annual Meeting in Lisbon, Portugal

Read More
November 3, 2016 - 04:01 AM

United Healthcare Issues Positive Coverage Decision for Optune

As of Jan. 1, 2017, more than 177 million Americans will have coverage of Optune as a treatment for newly diagnosed and/or recurrent…

Read More
Promoted Stories by dlvr.it
November 3, 2016 - 03:50 AM

NovaBay Pharmaceuticals to Hold Third Quarter 2016 Conference Call on November 10

Read More